ALMA VETERINARY SURGERY LTD
Company number 12795400 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ALMA VETERINARY SURGERY LTD - Analysis Report
Company Number: 12795400
Analysis Date: 2025-07-19 12:52 UTC
Industry Classification
Alma Veterinary Surgery Ltd operates within SIC code 75000, corresponding to "Veterinary activities." This sector encompasses veterinary care and treatment services for animals, including medical examinations, surgeries, vaccinations, and other health-related services. The UK veterinary services industry is characterised by a mix of small independent practices and larger corporate chains, with a strong emphasis on local community engagement, animal welfare standards, and increasingly, integration of digital health solutions. The sector is typically labour-intensive, reliant on skilled veterinary professionals and support staff, and sensitive to regulatory frameworks around animal health and pharmaceuticals.Relative Performance
Alma Veterinary Surgery Ltd is categorised as a small private limited company, with financial figures indicating modest scale relative to the veterinary sector. As of the year ending 31 December 2024, the company reports net assets of £34,173 and net current assets of £10,121, reflecting a positive working capital position after recent years of slight negative net current assets. Cash reserves at £72,126 suggest healthy liquidity. The company employs approximately 9 staff, which aligns with the typical size of a small veterinary practice serving a local catchment area. Compared to industry peers, Alma appears financially stable but modest in size; many veterinary practices in the UK generate annual revenues in the low millions, so Alma likely operates at a micro to small scale with lower turnover and asset base than larger regional or national chains.Sector Trends Impact
The UK veterinary sector is experiencing several impactful trends:
- Increasing pet ownership and willingness to spend on pet health drives demand growth.
- Rising operational costs, including pharmaceuticals, staffing, and compliance, pressure margins, especially for smaller practices.
- Digital transformation: telemedicine, electronic health records, and client communication platforms are becoming standard, requiring investment.
- Consolidation: corporate groups are acquiring independent practices, increasing competitive pressure on small independents.
- Regulatory changes around animal medicines and professional standards necessitate ongoing compliance costs.
Alma Veterinary Surgery Ltd’s scale and financial stability suggest it can manage day-to-day operations effectively but may face challenges competing with larger chains in marketing, technology adoption, and purchasing power. Continued focus on local client loyalty and quality service will be critical amid sector consolidation trends.
- Competitive Positioning
Strengths:
- Positive net asset growth year-over-year implies prudent financial management and potential for reinvestment.
- Healthy cash position supports operational stability and potentially modest capital expenditure.
- Small, focused staff base facilitates personalised client service, a key differentiator for local veterinary clinics.
Weaknesses: - Limited asset base and modest scale constrain ability to leverage economies of scale common in larger veterinary groups.
- Negative net current assets in prior years indicate occasional working capital tightness, requiring careful cash flow monitoring.
- Lack of publicly disclosed revenue and profitability data limits assessment but likely indicates modest turnover relative to sector averages.
- No evidence of significant investment in fixed assets growth in 2024 (net book value declined), which might limit expansion or technology upgrades.
Compared to typical UK veterinary competitors, Alma is a niche, locally focused player, not a sector leader or large chain affiliate. Its competitive advantage lies in community presence and potentially personalized care, though it may need to invest strategically to keep pace with technological and regulatory developments.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.